Hoenerhoff was a graduate fellow in the NCI molecular pathology GPP in partnership with Michigan State University from 2004-2008.
Dr. Hoenerhoff received his DVM from Michigan State University College of Veterinary Medicine in 1998, followed by three years working as a clinician in a small animal and emergency practice. In 2001, Dr. Hoenerhoff returned to Michigan State University to pursue a residency in anatomic veterinary pathology in the Department of Pathobiology and Diagnostic Investigation. Following completion of his residency, Dr. Hoenerhoff received board certification in by The American College of Veterinary Pathologists in 2004, while pursuing graduate training in comparative pathology through the Graduate Partnership Program at the National Cancer Institute at the National Institutes of Health in Bethesda, MD. His dissertation research focused on breast cancer biology, breast cancer stem cells, and genetically engineered mouse (GEM) models of breast cancer in the Transgenic Oncogenesis Laboratory, led by Jeffrey Green, M.D., in the Laboratory of Cancer Biology and Genetics. Dr. Hoenerhoff defended his dissertation research and received his PhD degree from Michigan State University in May of 2008. The title of his Ph.D. dissertation is “BMI1 collaborates with HRAS to promote mammary tumorigenesis and metastasis”. Members of his graduate guidance committee included: Thomas Mullaney, D.V.M. Ph.D., The American College of Veterinary Pathologists, (Chair); Kurt Williams, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists; P.S. MohanKumar, B.V.Sc., Ph.D; Michael Scott, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists; Vilma Yuzbasiyan-Gurkan, Ph.D.; Jeff Green, M.D. and Mark Simpson, D.V.M., Ph.D., Diplomate, The American College of Veterinary Pathologists. Following completion of his Ph.D., Dr. Hoenerhoff joined the Cellular and Molecular Pathology Branch at the National Institute of Environmental Health Sciences in the Research Triangle Park, NC, as Head of Investigative Pathology (2008-2013). His research focused on genetic and epigenetic mechanisms of chemically induced carcinogenesis and toxicity in National Toxicology Program (NTP) studies. He has now returned to Michigan, his home state, where he accepted a position at the University of Michigan, Ann Arbor, MI as an associate professor.
